Y-mabs partner seeks launch of cancer drug in Brazil
![Rio de Janeiro, Brazil | Photo: Jens Dresling](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14441415.ece/ALTERNATES/schema-16_9/doc7mxja7fy4ecarnl92ai.jpg)
Y-mabs is hoping to soon see its cancer drug, Danyelza, on the market in Brazil, announcing in a press release that the company’s partner, Adium Pharma, has submitted a regulatory filing in the country.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Israel approves Y-mabs cancer drug
For subscribers
Y-mabs reports second quarter sales increase for cancer drug
For subscribers